Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Title
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial
Authors
Keywords
Apical sodium-dependent bile acid transporter, Bile acids, Clinical pharmacology, Non-alcoholic steatohepatitis, Non-alcoholic fatty liver disease, Phase 1 clinical trial, LUM002, SHP626, Type 2 diabetes mellitus, Volixibat
Journal
BMC GASTROENTEROLOGY
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-05
DOI
10.1186/s12876-017-0736-0

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now